首页 | 本学科首页   官方微博 | 高级检索  
检索        

特许医疗政策下的药械真实世界数据研究常见设计及其关键考虑
引用本文:姚明宏,贾玉龙,任燕,刘艳梅,邹康,林凯,朱宁,孙鑫.特许医疗政策下的药械真实世界数据研究常见设计及其关键考虑[J].中华流行病学杂志,2021,42(7):1306-1311.
作者姓名:姚明宏  贾玉龙  任燕  刘艳梅  邹康  林凯  朱宁  孙鑫
作者单位:四川大学华西医院中国循证医学中心, 成都 610041;海南真实世界数据研究与评价重点实验室/海南真实世界数据研究院/海南博鳌乐城真实世界数据研究创新中心, 琼海 571435;海南博鳌先行区药品不良反应监测中心, 琼海 571435;海南省药品监督管理局, 海口 570216
基金项目:国家重点研发计划(2019YFC1709804,2017YFC1700406);四川省青年科技创新研究团队(2020JDTD0015);四川大学华西医院学科卓越发展1·3·5工程项目(ZYYC08003)
摘    要:博鳌乐城国际医疗旅游先行区是全国唯一的真实世界数据应用试点地区,基于博鳌乐城特许医疗政策,开展真实世界数据研究,形成支持创新药械临床评价和审评审批的真实世界证据,已成为我国药品审评审批制度改革的重要领域,真实世界证据的产生不仅依靠高质量的真实世界数据,还需要合理可靠的研究设计。本文在国内外相关学术研究和监管部门所发布的真实世界数据研究指导原则或规范的基础上,结合博鳌乐城特殊政策环境和前期实践经验,总结了博鳌乐城真实世界数据研究的设计类型,并探讨了各设计类型在博鳌乐城特殊医疗政策环境中的关键考虑,旨在为进一步实施和开展真实世界数据研究提供借鉴。

关 键 词:真实世界数据研究  设计类型  监管决策  博鳌乐城
收稿时间:2021/2/1 0:00:00

Real-world data studies of medical products in the context of special healthcare policy: study designs and key considerations
Yao Minghong,Jia Yulong,Ren Yan,Liu Yanmei,Zou Kang,Lin Kai,Zhu Ning,Sun Xin.Real-world data studies of medical products in the context of special healthcare policy: study designs and key considerations[J].Chinese Journal of Epidemiology,2021,42(7):1306-1311.
Authors:Yao Minghong  Jia Yulong  Ren Yan  Liu Yanmei  Zou Kang  Lin Kai  Zhu Ning  Sun Xin
Institution:Chinese Evidence-based Medicine Center, West China Hospital, Sichuan University, Chengdu 610041, China;Key Laboratory for Real World Data Research and Evaluation in Hainan/Real World Data Research Institute of Hainan/Real World Data Research and Innovation Center of Boao Lecheng, Qionghai 571435, China;Center for Adverse Drug Reaction Monitoring of Boao Pilot Zone, Qionghai 571435, China;National Medical Produets Administration, Haikou 570216, China
Abstract:Boao Lecheng International Medical Tourism Pilot Area is the only administrative area in China where the pilot application of real-world data is performed. Based on the special healthcare policy in Boao Lecheng, conducting real-world data study to provide real-world evidence for the clinical evaluations and approvals of innovated medical products has become an important field that supports the reform of China''s evaluation and approval system of medical products. Trustworthy real-world evidence needs to rely on both high-quality real-world data and reasonable and rigorous study designs. Based on the real-world data research guidelines and specifications issued by relevant academic research and regulatory authorities both at home and abroad, combined with the special policy environment of Boao Lecheng and previous practice experience, this paper summarizes the study designs of real world data in Boao Lecheng and discusses the key considerations of different study design in the context of special healthcare policies in Boao Lecheng in order to provide reference for the further study of real-world data.
Keywords:Real-world data study  Study design  Regulatory decision making  Boao Lecheng
点击此处可从《中华流行病学杂志》浏览原始摘要信息
点击此处可从《中华流行病学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号